泛谷药业 (837090.OC)

+ 收藏

财务分析(报告期)(泛谷药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2023年一季报2022年年报2022年中报2022年一季报
主要指标:
 营业收入(元) 209,781,867.86466,161,891.68209,154,773.3898,533,774.91532,300,205.21244,821,725.43-
 营业利润(元) 39,581,784.3987,007,465.1944,610,697.8616,863,051.51133,760,561.4883,532,537.55-
 利润总额(元) 39,728,269.8386,837,878.5044,550,451.2216,863,051.51133,490,385.0683,540,287.55-
 净利润(元) 31,744,148.5874,382,620.4837,704,551.3314,385,449.51110,798,964.0868,344,075.75-
 归属于母公司股东的净利润(元) 31,744,148.5874,382,620.4837,704,551.3314,385,449.51110,798,964.0868,344,075.75-
盈利能力:
 销售毛利率(%) 65.0267.8666.7566.2569.5071.2972.81
 销售净利率(%) 15.1315.9618.0314.6020.8227.9228.79
 净资产收益率(%) 12.8425.4812.64----
 总资产报酬率ROA(%) 11.3518.759.79----
 投入资本回报率ROIC(%) 12.7323.7711.733.7831.9019.4920.50
营运能力:
 存货周转率(次) 2.184.171.75----
 应收账款周转率(次) 4.828.235.67----
 总资产周转率(次) 0.601.080.52----
偿债能力:
 资产负债率(%) 29.5635.5428.5923.5930.3524.95-
 股东权益比率(%) 70.4464.4671.4176.4169.6575.05-
 已获利息倍数(倍) -297.08-14.37-8.2624.25-22.51-15.23-
 流动比率 2.042.123.264.063.163.88-
 速动比率 1.491.542.413.352.763.11-
发展能力:
 营业收入增长率(%) 0.30-12.43-14.57-19.288.1821.21-
 营业利润增长率(%) -11.27-34.95-46.59-62.1913.6049.96-
 税后利润增长率(%) -15.81-32.87-44.83-59.0713.3054.03-
 净资产增长率(%) 0.27-30.81-29.33-5.2021.07-
 总资产增长率(%) 1.65-25.21-25.72-12.4225.12-

前瞻产业研究院